Severity
Low
FDA Drug recall · Reported March 27, 2013
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Novartis Consumer Health recalled Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OT… - a low-severity action.
Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OT… was recalled by Novartis Consumer Health in March 27, 2013. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.. Check the official notice for the remedy. Verify recall #D-207-2013 with the FDA Drug before acting.
The recall
Novartis Consumer Health issued this low-severity FDA Drug recall-Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible..
Sourced from official FDA Drug enforcement records. Verify recall #D-207-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-207-2013) was formally reported on March 27, 2013, with the manufacturer initiating the action on March 7, 2013. It is classified under Low severity (Class III), with a current status of Terminated. Novartis Consumer Health is listed as the recalling firm, operating out of Lincoln, NE. Federal records list the affected scope as 240,120/2-oz. tubes and 429,144/4-oz. tubes.
The documented reason for this recall is: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. Distribution data in the federal record shows the product reached: Nationwide and Panama. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
240,120/2-oz. tubes and 429,144/4-oz. tubes
Related Recalls
6
3 from same agency
Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-207-2013 |
| Date reported | March 27, 2013 |
| Date initiated | March 7, 2013 |
| Recalling firm | Novartis Consumer Health |
| Firm location | Lincoln, NE |
| Affected scope | 240,120/2-oz. tubes and 429,144/4-oz. tubes |
| Distribution | Nationwide and Panama |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-06-04
PS Seasoning & Spices, Inc. · 2026-05-27
Fontana Flavors, Inc · 2026-05-27
Wisconsin Pharmacal Company · 2026-05-27
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-04-22
Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported March 27, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.